Newbridge Acquisition Limited Unit (NBRGU)
NBRGU trades on Nasdaq in Finance, Blank Checks. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$10.39
0.00% on the day
Market cap
SPAC unit: share + warrant bundle
Revenue
SPAC unit: share + warrant bundle
Net income
SPAC unit: share + warrant bundle
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | NBRGU on Nasdaq |
| Sector | Finance |
| Industry | Blank Checks |
| Country | Hong Kong |
| IPO year | 2026 |
| SEC CIK | 0001918414 |
| SEC industry code | Services-Prepackaged Software |
Financials
SPAC unit: share + warrant bundle.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS | 424B4 | 2026-01-30 |
| Latest annual report ANNUAL REPORT | 10-K | 2026-03-23 |
| Latest quarterly / interim QUARTERLY REPORT | 10-Q | 2026-08-07 |
| Latest current report CURRENT REPORT | 8-K | 2026-08-03 |
Source: SEC EDGAR submissions feed, 57 recent filings. All filings on EDGAR.
Other listings for this company
| Ticker | Name | Price |
|---|---|---|
| NBRG | Newbridge Acquisition Limited Class A Ordinary Share | $10.09 |
| NBRGR | Newbridge Acquisition Limited Rights | $0.4000 |
Peers in Blank Checks
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| DMII | Drugs Made In America Acquisition II Corp. | $10.19 | 0.00% | $649.1M |
| GUAC | Berto Acquisition Corp. II | $9.91 | 0.00% | $390.3M |
| TACO | Berto Acquisition Corp. | $10.47 | +0.14% | $381.7M |
| PRE | Prenetics Global Limited Class A Ordinary Share | $21.27 | +0.52% | $360.3M |
| IRHO | Iron Horse Acquisitions II Corp. | $10.07 | +0.05% | $295.3M |
| FGII | FG Imperii Acquisition Corp. | $10.03 | +0.10% | $290.3M |
| APMC | AmperCap Acquisition Company | $9.96 | 0.00% | $198.8M |
| QRED | QuasarEdge Acquisition Corporation | $10.08 | +0.10% | $161.7M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier